NCT01832636View on ClinicalTrials.gov

Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
MalnutritionEnvironmental EnteropathyDiarrhea
Interventions
DIETARY_SUPPLEMENT

Alanyl-Glutamine

Alanyl-Glutamine and Glycine doses will be prepared immediately prior to administration by dissolving in formula, milk, or fruit juice. Administration of each dose will be directly observed by a study nurse or health agent.

Trial Locations (1)

Unknown

Universidade Federal do Ceara, Fortaleza

All Listed Sponsors
collaborator

Universidade Federal do Ceara

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT01832636 - Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy | Biotech Hunter | Biotech Hunter